Lawrence G. Hamel

2016

In 2016, Lawrence G. Hamel earned a total compensation of $623.5K as Chief Development Officer at AcelRx Pharmaceuticals, a 28% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$113,393
Option Awards$165,495
Salary$334,000
Other$10,600
Total$623,488

Hamel received $334K in salary, accounting for 54% of the total pay in 2016.

Hamel also received $113.4K in non-equity incentive plan, $165.5K in option awards and $10.6K in other compensation.

Rankings

In 2016, Lawrence G. Hamel's compensation ranked 10,388th out of 14,075 executives tracked by ExecPay. In other words, Hamel earned more than 26.2% of executives.

ClassificationRankingPercentile
All
10,388
out of 14,075
26th
Division
Manufacturing
4,011
out of 5,486
27th
Major group
Chemicals And Allied Products
1,417
out of 1,900
25th
Industry group
Drugs
1,136
out of 1,543
26th
Industry
Pharmaceutical Preparations
887
out of 1,173
24th
Source: SEC filing on April 28, 2017.

Hamel's colleagues

We found five more compensation records of executives who worked with Lawrence G. Hamel at AcelRx Pharmaceuticals in 2016.

2016

Howard Rosen

AcelRx Pharmaceuticals

Chief Executive Officer

2016

Pamela Palmer

AcelRx Pharmaceuticals

Chief Medical Officer

2016

Timothy Morris

AcelRx Pharmaceuticals

Chief Financial Officer

2016

Jane Wright-Mitchell

AcelRx Pharmaceuticals

Chief Legal Officer

2016

Badri Dasu

AcelRx Pharmaceuticals

Chief Engineering Officer

News

You may also like